290 related articles for article (PubMed ID: 18272844)
1. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.
Vogt L; Waanders F; Boomsma F; de Zeeuw D; Navis G
J Am Soc Nephrol; 2008 May; 19(5):999-1007. PubMed ID: 18272844
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
[TBL] [Abstract][Full Text] [Related]
3. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
[TBL] [Abstract][Full Text] [Related]
4. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
5. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
Laverman GD; Navis G; Henning RH; de Jong PE; de Zeeuw D
Kidney Int; 2002 Sep; 62(3):1020-5. PubMed ID: 12164886
[TBL] [Abstract][Full Text] [Related]
6. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
7. Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD.
Wouda RD; Waanders F; de Zeeuw D; Navis G; Vogt L;
Clin Kidney J; 2021 Oct; 14(10):2170-2176. PubMed ID: 34603695
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function.
Slagman MC; Sinkeler SJ; Hemmelder MH; Waanders F; Vogt L; Kluin-Nelemans HC; Navis G; Laverman GD
Nephrol Dial Transplant; 2010 Oct; 25(10):3256-60. PubMed ID: 20339099
[TBL] [Abstract][Full Text] [Related]
9. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.
Buter H; Hemmelder MH; Navis G; de Jong PE; de Zeeuw D
Nephrol Dial Transplant; 1998 Jul; 13(7):1682-5. PubMed ID: 9681711
[TBL] [Abstract][Full Text] [Related]
10. Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis.
Rutkowski P; Tylicki L; Renke M; Korejwo G; Zdrojewski Z; Rutkowski B
Am J Kidney Dis; 2004 Feb; 43(2):260-8. PubMed ID: 14750091
[TBL] [Abstract][Full Text] [Related]
11. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
12. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension.
Saruta T; Ogihara T; Matsuoka H; Suzuki H; Toki M; Hirayama Y; Nonaka K; Takahashi K
Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
Ohma KP; Milon H; Valnes K
Blood Press; 2000; 9(4):214-20. PubMed ID: 11055474
[TBL] [Abstract][Full Text] [Related]
15. Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy.
Mirkovic K; Frenay AS; van den Born J; van Goor H; Navis G; de Borst MH;
Nephrol Dial Transplant; 2017 Aug; 32(8):1293-1301. PubMed ID: 26311058
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
17. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.
Kwakernaak AJ; Krikken JA; Binnenmars SH; Visser FW; Hemmelder MH; Woittiez AJ; Groen H; Laverman GD; Navis G;
Lancet Diabetes Endocrinol; 2014 May; 2(5):385-95. PubMed ID: 24795252
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].
Chazova IE; Martyniuk TV
Ter Arkh; 2013; 85(10):10-22. PubMed ID: 24437213
[TBL] [Abstract][Full Text] [Related]
19. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
20. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
